• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Oct 1:15:1427284.
doi: 10.3389/fimmu.2024.1427284. eCollection 2024. Virological characteristics of SARS-CoV-2 Omicron BA.5.2.48

Wenqi Wang[SUP] #[/SUP][SUP] 1 2 [/SUP], Qiushi Jin[SUP] #[/SUP][SUP] 2 3 [/SUP], Ruixue Liu[SUP] #[/SUP][SUP] 2 4 [/SUP], Wentao Zeng[SUP] #[/SUP][SUP] 5 [/SUP], Pengfei Zhu[SUP] 2 4 [/SUP], Tingting Li[SUP] 2 5 [/SUP], Tiecheng Wang[SUP] 2 [/SUP], Haiyang Xiang[SUP] 2 [/SUP], Hang Zhang[SUP] 6 [/SUP], Qin Chen[SUP] 5 [/SUP], Yun Gao[SUP] 5 [/SUP], Yana Lai[SUP] 5 [/SUP], Fang Yan[SUP] 4 [/SUP], Xianzhu Xia[SUP] 2 3 [/SUP], Jianmin Li[SUP] 5 [/SUP], Xuefeng Wang[SUP] 2 [/SUP], Yuwei Gao[SUP] 2 4 [/SUP]



Affiliations
Abstract

With the prevalence of sequentially-emerged sublineages including BA.1, BA.2 and BA.5, SARS-CoV-2 Omicron infection has transformed into a regional epidemic disease. As a sublineage of BA.5, the BA.5.2.48 outbroke and evolved into multi-subvariants in China without clearly established virological characteristics. Here, we evaluated the virological characteristics of two isolates of the prevalent BA.5.2.48 subvariant, DY.2 and DY.1.1 (a subvariant of DY.1). Compared to the normal BA.5 spike, the double-mutated DY.1.1 spike demonstrates efficient cleavage, reduced fusogenicity and higher hACE2 binding affinity. BA.5.2.48 demonstrated enhanced airborne transmission capacity than BA.2 in hamsters. The pathogenicity of BA.5.2.48 is greater than BA.2, as revealed in Omicron-lethal H11-K18-hACE2 rodents. In both naïve and convalescent hamsters, DY.1.1 shows stronger fitness than DY.2 in hamster turbinates. Thus regional outbreaking of BA.5.2.48 promotes the multidirectional evolution of its subvariants, gaining either enhanced pathogenicity or a fitness in upper airways which is associated with higher transmission.

Keywords: BA.5; Omicron; SARS-CoV-2; animal models; pathogenicity; spike.

 
Back
Top Bottom